Observational studyMedicine2020

Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease.

Yasuhiko Gotoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.